← Back to Search

Other

Ortho-R for Rotator Cuff Repair

Phase 1 & 2
Recruiting
Research Sponsored by Ortho Regenerative Technologies Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Surgically sterilized, or
Subject is ≥40 to ≤75 years.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-operative 3,6, and 12 months
Awards & highlights

Study Summary

This trial will compare a new combination treatment for rotator cuff repair against the current standard of care, assessing the results after 12 months.

Who is the study for?
This trial is for adults aged 40-75 with a primary symptomatic rotator cuff tear (1.5 to 4 cm) that can be repaired arthroscopically, who have tried at least two conservative treatments without success or are experiencing severe symptoms. Participants must not use NSAIDs around the surgery and follow-up visits, agree to contraception if of reproductive capacity, and commit to all study visits.Check my eligibility
What is being tested?
The trial is testing Ortho-R/PRP in combination with standard care for rotator cuff repair against standard care alone. It's a Phase I/II study where participants are randomly assigned to one of the two groups and their progress will be compared over a period of 12 months.See study design
What are the potential side effects?
While specific side effects aren't listed here, generally PRP therapy may cause pain at the injection site, tissue damage, infection or nerve injuries. Any surgical procedure carries risks like bleeding, infection or reaction to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have undergone surgical sterilization.
Select...
I am between 40 and 75 years old.
Select...
I have a tear in my shoulder's rotator cuff that can be surgically fixed.
Select...
I am postmenopausal.
Select...
I can move my arm just like my other arm that wasn't affected.
Select...
My rotator cuff tear was fixed using a camera and tools through small cuts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-operative 3,6, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-operative 3,6, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Complications
Incidence of cuff re-tears
Secondary outcome measures
Analysis of cuff integrity
Change from baseline Constant-Mulrey Score
Change from baseline Euro Quality of Life five questionnaire EQ-5D-5L
+3 more
Other outcome measures
Hematology testing Comprehensive Metabolic panel
Whole blood and PRP (Plasma Rich Platelets) to be collected

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Investigational Arm with Ortho-R/PRPExperimental Treatment1 Intervention
Using a double row, Trans-osseous Equivalent Rotator Cuff Repair Technique (TOE) with Ortho-R/PRP combination
Group II: Control Arm Standard of Care without Ortho-R/PRPActive Control1 Intervention
Using the Trans-osseous Equivalent Rotator Cuff Repair Technique (TOE) without Ortho-R/PRP combination

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

MCRA, LLCIndustry Sponsor
18 Previous Clinical Trials
7,645 Total Patients Enrolled
Ortho Regenerative Technologies IncLead Sponsor
ChitogenX IncLead Sponsor

Media Library

Ortho-R/PRP (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05333211 — Phase 1 & 2
Rotator Cuff Tears Research Study Groups: Investigational Arm with Ortho-R/PRP, Control Arm Standard of Care without Ortho-R/PRP
Rotator Cuff Tears Clinical Trial 2023: Ortho-R/PRP Highlights & Side Effects. Trial Name: NCT05333211 — Phase 1 & 2
Ortho-R/PRP (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05333211 — Phase 1 & 2
~28 spots leftby May 2025